The AMPK/PPAR-γ/PGC-1α signalling pathway is involved in the anti-obesity effects of adiponectin (57, 58), while both adiponectin (34, 59–61) and physical exercise (34, 36) activate the AMPK signalling pathway. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.